top of page

News
MitoSense Secures Japanese Patent for Groundbreaking Mitochondria-Based Therapy for Neurodegenerative Diseases
February 4, 2025 – Plymouth, MA – MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, is...
Feb 3
MitoSense, Inc. Secures U.S. Patent for Innovative Treatment of Neurodegenerative Diseases
Plymouth, MA, Dec 2, 2024 – MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative...
Dec 2, 2024
MitoSense Inc. Publishes Breakthrough Study on Cryopreserved Fibroblast and Mesenchymal Stem Cells as Alternative Mitochondrial Donors
Plymouth, MA – November 12, 2024 – MitoSense Inc., a leader in mitochondria lresearch and innovation, proudly announces the publication...
Nov 12, 2024


MitoSense Applauds Elliott Mitochondria Research Center's Benefit Concert: A Night to END ALS & TBI
September 6, 2024 – Tampa, FL  – MitoSense, holder of an exclusive license on groundbreaking technology from the Elliott Mitochondria...
Sep 6, 2024


MitoSense to Attend MHSRS, August 26th -29th
MitoSense, Inc. is proud to announce its participation in the 2024 Military Health System Research Symposium (MHSRS), taking place August...
Aug 19, 2024

MitoSense is Accepted into NVIDIA's Inception Program
We are thrilled to announce that MitoSense Inc. has been accepted into the prestigious NVIDIA Inception Program! This milestone marks a...
Jul 29, 2024


MitoSense Chief Medical Officer Submits Statement for the Record to U.S. House VA Committee Hearing
MitoSense's Chief Medical Officer, Dr. Catherine Baucom, has been invited to provide a Statement for the Record for the U.S. House of...
Jun 13, 2024
Hop On A Cure Foundation Announces Investment in MitoSense’s MOT™ Technology to Revolutionize ALS Treatment
SOURCE: Hop On A Cure ATLANTA, Ga. (January 30, 2024) - Nonprofit foundation Hop On A Cure, a leading advocate in the fight against ALS,...
Jan 30, 2024
bottom of page